Tracey believes supporting cancer research is more important now than ever before, and she is grateful to the people who dedicate their time and talents to raising funds for Roswell Park.
SurVaxM
Every year, more than 4,000 children and teens in the U.S. develop brain and spinal cord tumors, which are second only to leukemia as the most common childhood cancers. Can SurVaxM, a pioneering brain cancer immunotherapy developed at Roswell Park, work for younger patients?
After going through treatment the second time, I began a successful recovery and wanted to find a way to give back and help fight the terrible disease that has affected my life and the lives of so many others.